mylan-will-develop-and-market-insulin-generics-including-biocon-s-glargine-lispro-and-aspart

Mylan to develop, market Biocon generic insulin

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US,... Read more

australia-is-currently-focusing-on-providing-its-people-with-the-tools-to-support-independent-aging-care-and-improve-healthcare-services-in-remote-regions

Physicians, consumers lack trust in Aus healthcare

  • Australia
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. The country spent 9.3 percent of its GDP on... Read more

mireven-study-demonstrates-the-anti-cancer-potential-of-micro-rna-mir-7

MiReven micro RNA 'miR-7-5p' inhibits melanoma

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: MiReven, an Australian micro RNA (miRNA) company that is involved in commercializing discoveries from the Western Australian Institute for Medical Research... Read more

china-based-changchun-bcht-biotechnology-pays-usd100-000-to-biodiem-for-its-live-attenuated-influenza-virus-laiv-vaccine-technology

BioDiem gets paid for its vaccine technology

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received an early annual maintenance payment from its Chinese partner,... Read more

mr-jackson-huang-winner-of-the-australian-brain-bee-challenge-abcc-has-been-named-australia-s-neuroscientist-of-the-future

High school kid named ‘neuroscientist of the future'

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mr Jackson Huang from the Queensland Academy of Science, Mathematics and Technology, has been named Australia's ‘neuroscientist of the future' after... Read more

cytomedix-platelet-rich-plasma-preparation-device-angel-cprp-system-gets-nod-from-therapeutic-goods-administration-in-australia

Cytomedix plasma preparation device gets TGA nod

  • Australia
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Cytomedix's Angel cPRP System has been listed by the TGA (Therapeutic Goods Administration) in Australia. Following this, Angel will be marketed and... Read more

cellmid-to-supply-anti-midkine-diagnostic-antibodies-to-fujikura-kasei

Cellmid to supply diagnostic antibodies to Fujikura

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major supplier of latex particles used in medical diagnostics. Under... Read more

avita-appointment

Avita Medical appoints Michael Perry to board

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Regenerative medicine company Avita Medical, listed on ASX, has appointed Dr Michael S Perry, vice president and senior global program head, Stem Cell... Read more

patent-notice-of-allowance

AmpliPhi gets notice of allowance on key patent application...

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AmpliPhi Biosciences, the anti-infective company focused on developing phage-based therapies to combat the growing threat of antibiotic-resistant infection,... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X